(R)-albuterol decreases immune responses: Role of activated T cells

Respiratory Research

Volumn 9, Issue , 2008, Pages

  Ferrada, Marcela A ^a,b   Gordon, Erin L ^b   Jen, Kai Y ^a,b   He, Hong Z ^a,b   Lu, Xin ^a,b   Barone, Leesa M ^c   Amirifeli, Sepideh ^a,b   Perkins, David L ^a,b   Finn, Patricia W ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^c SUNOVION PHARMACEUTICALS INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; IMMUNOGLOBULIN E; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; ISOPROTEIN; OVALBUMIN; SALBUTAMOL;

ANIMAL; ARTICLE; C57BL MOUSE; CELL CULTURE; CELL LINE; DISEASE MODEL; DRUG EFFECT; EOSINOPHIL; FEMALE; HYPERSENSITIVITY; IMMUNOLOGY; INFLAMMATION; LUNG DISEASE; METABOLISM; MOUSE; PATHOLOGY; PNEUMONIA; SPLEEN; T LYMPHOCYTE;

ADRENERGIC BETA-AGONISTS; ALBUTEROL; ANIMALS; CELL LINE; CELLS, CULTURED; DISEASE MODELS, ANIMAL; EOSINOPHILS; FEMALE; HYPERSENSITIVITY; IMMUNOGLOBULIN E; INFLAMMATION; LUNG DISEASES; MICE; MICE, INBRED C57BL; NF-KAPPA B; OVALBUMIN; PNEUMONIA; PROTEIN ISOFORMS; SPLEEN; T-LYMPHOCYTES;

EID: 68949120471     PISSN: 14659921     EISSN: 1465993X     Source Type: Journal    
DOI: 10.1186/1465-9921-9-3     Document Type: Article

References (50)

1. Doganci A, Eigenbrod T, Krug N, De Sanctis GT, Hausding M, Erpenbeck VJ, Haddad el B, Lehr HA, Schmitt E, Bopp T. The IL-6R alpha chain controls lung CD4+CD25+ Treg development and function during allergic airway inflammation in vivo. J Clin Invest 2005, 115(2):313-325. 544603, 15668741, 10.1172/JCI200522433.
2. Costello PS, Turner M, Walters AE, Cunningham CN, Bauer PH, Downward J, Tybulewicz VL. Critical role for the tyrosine kinase Syk in signalling through the high affinity IgE receptor of mast cells. Oncogene 1996, 13(12):2595-2605.
3. Mekori YA, Metcalfe DD. Mast cell-T cell interactions. The Journal of allergy and clinical immunology 1999, 104(3 Pt 1):517-523.
4. Nigo YI, Yamashita M, Hirahara K, Shinnakasu R, Inami M, Kimura M, Hasegawa A, Kohno Y, Nakayama T. Regulation of allergic airway inflammation through Toll-like receptor 4-mediated modification of mast cell function. Proc Natl Acad Sci USA 2006, 103(7):2286-2291. 1413725, 16461458, 10.1073/pnas.0510685103.
5. Bodey KJ, Semper AE, Redington AE, Madden J, Teran LM, Holgate ST, Frew AJ. Cytokine profiles of BAL T cells and T-cell clones obtained from human asthmatic airways after local allergen challenge. Allergy 1999, 54(10):1083-1093. 10.1034/j.1398-9995.1999.00889.x, 10536887.
6. Robinson D, Hamid Q, Bentley A, Ying S, Kay AB, Durham SR. Activation of CD4+ T cells, increased TH2-type cytokine mRNA expression, and eosinophil recruitment in bronchoalveolar lavage after allergen inhalation challenge in patients with atopic asthma. The Journal of allergy and clinical immunology 1993, 92(2):313-324.
7. Robinson DS, Hamid Q, Ying S, Tsicopoulos A, Barkans J, Bentley AM, Corrigan C, Durham SR, Kay AB. Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma. N Engl J Med 1992, 326(5):298-304.
8. Krinzman SJ, De Sanctis GT, Cernadas M, Mark D, Wang Y, Listman J, Kobzik L, Donovan C, Nassr K, Katona I. Inhibition of T cell costimulation abrogates airway hyperresponsiveness in a murine model. J Clin Invest 1996, 98(12):2693-2699. 507732, 8981913.
9. Arestides RS, He H, Westlake RM, Chen AI, Sharpe AH, Perkins DL, Finn PW. Costimulatory molecule OX40L is critical for both Th1 and Th2 responses in allergic inflammation. Eur J Immunol 2002, 32(10):2874-2880. 10.1002/1521-4141(2002010)32:10<2874::AID-IMMU2874>3.0.CO;2-4, 12355440.
10. Loza MJ, Foster S, Peters SP, Penn RB. Beta-agonists modulate T-cell functions via direct actions on type 1 and type 2 cells. Blood 2006, 107(5):2052-2060. 1895713, 16278302, 10.1182/blood-2005-08-3265.
11. Johnson M. Effects of beta2-agonists on resident and infiltrating inflammatory cells. J Allergy Clin Immunol 2002, 110(6 Suppl):S282-290. 10.1067/mai.2002.129430, 12464937.
12. Williams LT, Snyderman R, Lefkowitz RJ. Identification of beta-adrenergic receptors in human lymphocytes by (-) (3H) alprenolol binding. The Journal of clinical investigation 1976, 57(1):149-155. 436634, 1245597.
13. Page CP, Morley J. Contrasting properties of albuterol stereoisomers. The Journal of allergy and clinical immunology 1999, 104(2 Pt 2):S31-41.
14. Gumbhir-Shah K, Kellerman DJ, DeGraw S, Koch P, Jusko WJ. Pharmacokinetic and pharmacodynamic characteristics and safety of inhaled albuterol enantiomers in healthy volunteers. J Clin Pharmacol 1998, 38(12):1096-1106.
15. Gumbhir-Shah K, Kellerman DJ, DeGraw S, Koch P, Jusko WJ. Pharmacokinetics and pharmacodynamics of cumulative single doses of inhaled salbutamol enantiomers in asthmatic subjects. Pulm Pharmacol Ther 1999, 12(6):353-362. 10.1006/pupt.1999.0217, 10587476.
16. Templeton AG, Chapman ID, Chilvers ER, Morley J, Handley DA. Effects of S-salbutamol on human isolated bronchus. Pulm Pharmacol Ther 1998, 11(1):1-6. 10.1006/pupt.1998.0110, 9802957.
17. Mazzoni L, Naef R, Chapman ID, Morley J. Hyperresponsiveness of the airways following exposure of guinea-pigs to racemic mixtures and distomers of beta 2-selective sympathomimetics. Pulm Pharmacol 1994, 7(6):367-376. 10.1006/pulp.1994.1043, 7549224.
18. Ibe BO, Portugal AM, Raj JU. Levalbuterol inhibits human airway smooth muscle cell proliferation: therapeutic implications in the management of asthma. Int Arch Allergy Immunol 2006, 139(3):225-236. 10.1159/000091168, 16446544.
19. Baramki D, Koester J, Anderson AJ, Borish L. Modulation of T-cell function by (R)- and (S)-isomers of albuterol: anti-inflammatory influences of (R)-isomers are negated in the presence of the (S)-isomer. J Allergy Clin Immunol 2002, 109(3):449-454. 10.1067/mai.2002.122159, 11897990.
20. Berthiaume Y, Lesur O, Dagenais A. Treatment of adult respiratory distress syndrome: plea for rescue therapy of the alveolar epithelium. Thorax 1999, 54(2):150-160.
21. Donovan CE, Mark DA, He HZ, Liou HC, Kobzik L, Wang Y, De Sanctis GT, Perkins DL, Finn PW. NF-kappa B/Rel transcription factors: c-Rel promotes airway hyperresponsiveness and allergic pulmonary inflammation. J Immunol 1999, 163(12):6827-6833.
22. Birrell MA, Hardaker E, Wong S, McCluskie K, Catley M, De Alba J, Newton R, Haj-Yahia S, Pun KT, Watts CJ. Ikappa-B kinase-2 inhibitor blocks inflammation in human airway smooth muscle and a rat model of asthma. Am J Respir Crit Care Med 2005, 172(8):962-971. 10.1164/rccm.200412-1647OC, 16002568.
23. Velasco G, Campo M, Manrique OJ, Bellou A, He H, Arestides RS, Schaub B, Perkins DL, Finn PW. Toll-like receptor 4 or 2 agonists decrease allergic inflammation. Am J Respir Cell Mol Biol 2005, 32(3):218-224. 10.1165/rcmb.2003-0435OC, 15576672.
24. Krinzman SJ, De Sanctis GT, Cernadas M, Kobzik L, Listman JA, Christiani DC, Perkins DL, Finn PW. T cell activation in a murine model of asthma. Am J Physiol 1996, 271(3 Pt 1):L476-483.
25. Libermann TA, Baltimore D. Activation of interleukin-6 gene expression through the NF-kappa B transcription factor. Molecular and cellular biology 1990, 10(5):2327-2334.
26. Devergne O, Cahir McFarland ED, Mosialos G, Izumi KM, Ware CF, Kieff E. Role of the TRAF binding site and NF-kappaB activation in Epstein-Barr virus latent membrane protein 1-induced cell gene expression. J Virol 1998, 72(10):7900-7908. 110117, 9733827.
27. Mitchell T, Sugden B. Stimulation of NF-kappa B-mediated transcription by mutant derivatives of the latent membrane protein of Epstein-Barr virus. J Virol 1995, 69(5):2968-2976. 188996, 7707523.
28. Romagnani S. Regulation of the T cell response. Clin Exp Allergy 2006, 36(11):1357-1366. 10.1111/j.1365-2222.2006.02606.x, 17083345.
29. Aronica MA, Mora AL, Mitchell DB, Finn PW, Johnson JE, Sheller JR, Boothby MR. Preferential role for NF-kappa B/Rel signaling in the type 1 but not type 2 T cell-dependent immune response in vivo. J Immunol 1999, 163(9):5116-5124.
30. Sanders VM, Baker RA, Ramer-Quinn DS, Kasprowicz DJ, Fuchs BA, Street NE. Differential expression of the beta2-adrenergic receptor by Th1 and Th2 clones: implications for cytokine production and B cell help. J Immunol 1997, 158(9):4200-4210.
31. Heijink IH, van den Berge M, Vellenga E, de Monchy JG, Postma DS, Kauffman HF. Altered beta2-adrenergic regulation of T cell activity after allergen challenge in asthma. Clin Exp Allergy 2004, 34(9):1356-1363. 10.1111/j.1365-2222.2004.02037.x, 15347367.
32. Volcheck GW, Kelkar P, Bartemes KR, Gleich GJ, Kita H. Effects of (R)- and (S)-isomers of beta-adrenergic agonists on eosinophil response to interleukin-5. Clin Exp Allergy 2005, 35(10):1341-1346. 10.1111/j.1365-2222.2005.02347.x, 16238794.
33. Abraha D, Cho SH, Agrawal DK, Park JM, Oh CK. (S, S)-formoterol increases the production of IL-4 in mast cells and the airways of a murine asthma model. Int Arch Allergy Immunol 2004, 133(4):380-388. 10.1159/000077358, 15031612.
34. Henderson WR, Banerjee ER, Chi EY. Differential effects of (S)- and (R)-enantiomers of albuterol in a mouse asthma model. J Allergy Clin Immunol 2005, 116(2):332-340. 10.1016/j.jaci.2005.04.013, 16083788.
35. Tomlinson PR, Wilson JW, Stewart AG. Salbutamol inhibits the proliferation of human airway smooth muscle cells grown in culture: relationship to elevated cAMP levels. Biochem Pharmacol 1995, 49(12):1809-1819. 10.1016/0006-2952(94)00532-Q, 7598743.
36. Pang L, Knox AJ. Regulation of TNF-alpha-induced eotaxin release from cultured human airway smooth muscle cells by beta2-agonists and corticosteroids. Faseb J 2001, 15(1):261-269. 10.1096/fj.00-0103com, 11149914.
37. Leff AR, Herrnreiter A, Naclerio RM, Baroody FM, Handley DA, Munoz NM. Effect of enantiomeric forms of albuterol on stimulated secretion of granular protein from human eosinophils. Pulm Pharmacol Ther 1997, 10(2):97-104. 10.1006/pupt.1997.0082, 9425641.
38. Heijink IH, Vellenga E, Borger P, Postma DS, Monchy JG, Kauffman HF. Polarized Th1 and Th2 cells are less responsive to negative feedback by receptors coupled to the AC/cAMP system compared to freshly isolated T cells. Br J Pharmacol 2003, 138(8):1441-1450. 1573801, 12721099, 10.1038/sj.bjp.0705193.
39. Farmer P, Pugin J. beta-adrenergic agonists exert their "anti-inflammatory" effects in monocytic cells through the IkappaB/NF-kappaB pathway. Am J Physiol Lung Cell Mol Physiol 2000, 279(4):L675-682.
40. Mitra S, Ugur M, Ugur O, Goodman HM, McCullough JR, Yamaguchi H. (S)-Albuterol increases intracellular free calcium by muscarinic receptor activation and a phospholipase C-dependent mechanism in airway smooth muscle. Mol Pharmacol 1998, 53(3):347-354.
41. Borgonovo B, Casorati G, Frittoli E, Gaffi D, Crimi E, Burastero SE. Recruitment of circulating allergen-specific T lymphocytes to the lung on allergen challenge in asthma. The Journal of allergy and clinical immunology 1997, 100(5):669-678.
42. Lara-Marquez ML, Deykin A, Krinzman S, Listman J, Israel E, He H, Christiani DC, Perkins DL, Finn PW. Analysis of T-cell activation after bronchial allergen challenge in patients with atopic asthma. The Journal of allergy and clinical immunology 1998, 101(5):699-708.
43. Nakajima H, Takatsu K. Role of Cytokines in Allergic Airway Inflammation. Int Arch Allergy Immunol 2006, 142(4):265-273. 10.1159/000097357, 17124428.
44. Kane LP, Lin J, Weiss A. It's all Rel-ative: NF-kappaB and CD28 costimulation of T-cell activation. Trends Immunol 2002, 23(8):413-420. 10.1016/S1471-4906(02)02264-0, 12133805.
45. Wills-Karp M. Interleukin-13 in asthma pathogenesis. Immunological reviews 2004, 202:175-190. 10.1111/j.0105-2896.2004.00215.x, 15546393.
46. Baeuerle PA, Henkel T. Function and activation of NF-kappa B in the immune system. Annu Rev Immunol 1994, 12:141-179.
47. Siebenlist U, Franzoso G, Brown K. Structure, regulation and function of NF-kappa B. Annu Rev Cell Biol 1994, 10:405-455. 10.1146/annurev.cb.10.110194.002201, 7888182.
48. Ziegelbauer K, Gantner F, Lukacs NW, Berlin A, Fuchikami K, Niki T, Sakai K, Inbe H, Takeshita K, Ishimori M. A selective novel low-molecular-weight inhibitor of IkappaB kinase-beta (IKK-beta) prevents pulmonary inflammation and shows broad anti-inflammatory activity. British journal of pharmacology 2005, 145(2):178-192. 1576128, 15753951, 10.1038/sj.bjp.0706176.
49. Hart LA, Krishnan VL, Adcock IM, Barnes PJ, Chung KF. Activation and localization of transcription factor, nuclear factor-kappaB, in asthma. American journal of respiratory and critical care medicine 1998, 158(5 Pt 1):1585-1592.
50. Verweij CL, Geerts M, Aarden LA. Activation of interleukin-2 gene transcription via the T-cell surface molecule CD28 is mediated through an NF-kB-like response element. J Biol Chem 1991, 266(22):14179-14182.